Augustina Isioma Ikusemoro: Kell Blood Group System – Clinical Significance and Transfusion Practice
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Today, I had the pleasure of delivering an internal lecture on the Kell Blood Group System as part of our Continuous Professional Development at the Sharjah Blood Transfusion and Research Center.
We explored the clinical significance of Kell antigens, their role in red-cell alloimmunisation and haemolytic disease of the fetus and newborn, and the implications for transfusion practice.
We also discussed emerging approaches to managing alloimmunised pregnancies, while recognising that current surveillance and care standards remain essential.
Thank you to my colleagues for your participation and thoughtful discussion.
Continuing to share knowledge across our teams helps strengthen transfusion practice and support safer care for patients.”
Stay updated with Hemostasis Today.
-
Oct 1, 2026, 12:15Stefan Hofer: Teamwork in Action – Managing Postpartum Hemorrhage
-
Oct 1, 2026, 12:12Louise St. Germain Bannon: Women’s Health Moves to the Center of the Global Health Agenda
-
Oct 1, 2026, 11:38Isabella Presch: Better Medicines for Children – Advancing Pediatric Clinical Research
-
Oct 1, 2026, 11:17Elastic Stockings for VTE Prevention – RPTH Journal
-
Oct 1, 2026, 10:34Thomas Vallim: New Protocol Improves Measurement of AAV-CRISPR Gene Editing
-
Oct 1, 2026, 10:05Guillaume Baudry: Landmark Clinical Trials Shaping Modern Heart Failure Therapy
-
Oct 1, 2026, 09:48Lesley Van Wyk: JAMA – A Newly Identified Blood Group System
-
Oct 1, 2026, 09:19Pauline Schuitema: Lipemic Index May Help Identify Severe Lipid Disorders
-
Oct 1, 2026, 07:52Marc Carrier: TRIM-Line Trial Evaluates VTE Prevention in Cancer